Literature DB >> 10906204

Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.

F G da Fonseca1, E J Wolffe, A Weisberg, B Moss.   

Abstract

The vaccinia virus H3L open reading frame encodes a 324-amino-acid immunodominant membrane component of virus particles. Biochemical and microscopic studies demonstrated that the H3L protein was expressed late in infection, accumulated in the cytoplasmic viral factory regions, and associated primarily with amorphous material near immature virions and with intracellular virion membranes. Localization of the H3L protein on the surfaces of viral particles and anchorage via the hydrophobic tail were consistent with its extraction by NP-40 in the absence of reducing agents, its trypsin sensitivity, its reactivity with a membrane-impermeable biotinylation reagent, and its immunogold labeling with an antibody to a peptide comprising amino acids 247 to 259. The H3L protein, synthesized in a coupled in vitro transcription/translation system, was tightly anchored to membranes as determined by resistance to Na(2)CO(3) (pH 11) extraction and cytoplasmically oriented as shown by sensitivity to proteinase K digestion. Further studies demonstrated that membrane insertion of the H3L protein occurred posttranslationally and that the C-terminal hydrophobic domain was necessary and sufficient for this to occur. These data indicated that the H3L protein is a member of the C-terminal anchor family and supported a model in which it is synthesized on free ribosomes and inserts into the membranes of viral particles during their maturation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906204      PMCID: PMC112271          DOI: 10.1128/jvi.74.16.7508-7517.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Vaccinia virus reexamined: development and release.

Authors:  C Morgan
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

3.  A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

Authors:  J F Rodriguez; E Paez; M Esteban
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

5.  The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses.

Authors:  T Betakova; E J Wolffe; B Moss
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.

Authors:  E J Wolffe; S Vijaya; B Moss
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

7.  Identification of the gene encoding vaccinia virus immunodominant protein p35.

Authors:  V V Zinoviev; N A Tchikaev; E G Malygin
Journal:  Gene       Date:  1994-09-30       Impact factor: 3.688

Review 8.  An update on the vaccinia virus genome.

Authors:  G P Johnson; S J Goebel; E Paoletti
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

9.  Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix.

Authors:  M I Vázquez; G Rivas; D Cregut; L Serrano; M Esteban
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  51 in total

1.  Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.

Authors:  A D Garcia; B Moss
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.

Authors:  Patricia Szajner; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  The adenovirus E3-6.7K protein adopts diverse membrane topologies following posttranslational translocation.

Authors:  Alexander R Moise; Jason R Grant; Roger Lippé; Reinhard Gabathuler; Wilfred A Jefferies
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane.

Authors:  Jason Mercer; Paula Traktman
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 9.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

10.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.